PortfoliosLab logo
China Medical System Holdings Ltd (0867.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG211081248

IPO Date

Jun 26, 2007

Highlights

Market Cap

HK$21.25B

PE Ratio

12.01

Year Range

HK$6.09 - HK$10.28

Target Price

HK$10.65

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in China Medical System Holdings Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


250.00%300.00%350.00%400.00%NovemberDecember2025FebruaryMarchApril
335.63%
381.34%
0867.HK (China Medical System Holdings Ltd)
Benchmark (^GSPC)

Returns By Period

China Medical System Holdings Ltd had a return of 12.98% year-to-date (YTD) and 22.61% in the last 12 months. Over the past 10 years, China Medical System Holdings Ltd had an annualized return of -1.35%, while the S&P 500 had an annualized return of 10.27%, indicating that China Medical System Holdings Ltd did not perform as well as the benchmark.


0867.HK

YTD

12.98%

1M

7.84%

6M

3.52%

1Y

22.61%

5Y*

3.43%

10Y*

-1.35%

^GSPC (Benchmark)

YTD

-6.06%

1M

-1.00%

6M

-4.87%

1Y

8.34%

5Y*

14.11%

10Y*

10.27%

*Annualized

Monthly Returns

The table below presents the monthly returns of 0867.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-6.49%16.29%-9.26%14.50%12.98%
2024-19.08%14.82%-36.08%-14.72%-4.64%0.15%-2.11%12.44%25.70%-12.96%0.51%-3.58%-43.54%
202310.10%-12.72%5.08%4.84%-13.56%16.00%2.66%-13.59%7.97%5.40%20.16%-7.86%18.65%
2022-0.31%6.78%-10.97%-5.46%2.11%5.52%2.12%-6.88%-17.07%-8.54%32.09%8.48%-0.21%
202128.64%8.80%26.90%18.59%10.56%2.76%-22.93%-3.30%-4.94%-6.62%-3.17%1.40%55.43%
2020-6.95%-8.05%-12.60%10.13%-4.44%5.03%2.85%-4.53%-2.51%-4.81%-2.46%9.34%-19.67%
201911.68%1.60%-7.87%-6.45%-0.72%3.77%5.31%32.51%-4.70%14.38%4.50%0.72%61.28%
2018-7.90%-6.32%13.36%9.63%-2.38%-17.04%-14.41%-3.13%-15.15%-14.25%-8.57%-14.65%-59.12%
20173.58%-0.63%9.02%-1.49%2.83%-2.32%-1.19%7.95%-4.26%5.72%13.18%11.64%51.47%
2016-20.84%9.51%8.69%-5.25%10.10%6.11%-3.39%14.04%1.26%-7.06%6.77%-5.10%9.57%
20154.37%-4.04%-7.16%14.93%-4.93%-16.07%-5.16%-17.28%5.34%20.63%0.00%6.73%-9.27%
20147.36%12.02%-11.94%4.56%0.06%4.06%1.48%17.19%18.57%7.68%-7.83%-2.73%56.95%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 0867.HK is 69, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 0867.HK is 6969
Overall Rank
The Sharpe Ratio Rank of 0867.HK is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of 0867.HK is 6969
Sortino Ratio Rank
The Omega Ratio Rank of 0867.HK is 6666
Omega Ratio Rank
The Calmar Ratio Rank of 0867.HK is 6969
Calmar Ratio Rank
The Martin Ratio Rank of 0867.HK is 6868
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for China Medical System Holdings Ltd (0867.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for 0867.HK, currently valued at 0.56, compared to the broader market-2.00-1.000.001.002.003.00
0867.HK: 0.56
^GSPC: 0.46
The chart of Sortino ratio for 0867.HK, currently valued at 1.08, compared to the broader market-6.00-4.00-2.000.002.004.00
0867.HK: 1.08
^GSPC: 0.77
The chart of Omega ratio for 0867.HK, currently valued at 1.13, compared to the broader market0.501.001.502.00
0867.HK: 1.13
^GSPC: 1.11
The chart of Calmar ratio for 0867.HK, currently valued at 0.34, compared to the broader market0.001.002.003.004.005.00
0867.HK: 0.34
^GSPC: 0.47
The chart of Martin ratio for 0867.HK, currently valued at 1.31, compared to the broader market-5.000.005.0010.0015.0020.00
0867.HK: 1.31
^GSPC: 1.94

The current China Medical System Holdings Ltd Sharpe ratio is 0.56. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of China Medical System Holdings Ltd with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.56
0.41
0867.HK (China Medical System Holdings Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

China Medical System Holdings Ltd provided a 2.93% dividend yield over the last twelve months, with an annual payout of HK$0.25 per share.


1.00%2.00%3.00%4.00%5.00%HK$0.00HK$0.10HK$0.20HK$0.30HK$0.40HK$0.50HK$0.6020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
DividendHK$0.25HK$0.25HK$0.62HK$0.62HK$0.56HK$0.37HK$0.38HK$0.35HK$0.28HK$0.22HK$0.18HK$0.15

Dividend yield

2.93%3.31%4.45%5.02%4.30%4.31%3.37%4.79%1.55%1.78%1.61%1.19%

Monthly Dividends

The table displays the monthly dividend distributions for China Medical System Holdings Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2024HK$0.00HK$0.00HK$0.00HK$0.00HK$0.09HK$0.00HK$0.00HK$0.16HK$0.00HK$0.00HK$0.00HK$0.00HK$0.25
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.27HK$0.00HK$0.00HK$0.00HK$0.34HK$0.00HK$0.00HK$0.00HK$0.62
2022HK$0.00HK$0.00HK$0.00HK$0.28HK$0.00HK$0.00HK$0.00HK$0.00HK$0.34HK$0.00HK$0.00HK$0.00HK$0.62
2021HK$0.00HK$0.00HK$0.00HK$0.24HK$0.00HK$0.00HK$0.00HK$0.00HK$0.32HK$0.00HK$0.00HK$0.00HK$0.56
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.14HK$0.00HK$0.23HK$0.00HK$0.00HK$0.00HK$0.00HK$0.37
2019HK$0.00HK$0.00HK$0.00HK$0.17HK$0.00HK$0.00HK$0.00HK$0.21HK$0.00HK$0.00HK$0.00HK$0.00HK$0.38
2018HK$0.00HK$0.00HK$0.00HK$0.17HK$0.00HK$0.00HK$0.00HK$0.00HK$0.18HK$0.00HK$0.00HK$0.00HK$0.35
2017HK$0.00HK$0.00HK$0.00HK$0.13HK$0.00HK$0.00HK$0.00HK$0.00HK$0.15HK$0.00HK$0.00HK$0.00HK$0.28
2016HK$0.00HK$0.00HK$0.00HK$0.10HK$0.00HK$0.00HK$0.00HK$0.00HK$0.12HK$0.00HK$0.00HK$0.00HK$0.22
2015HK$0.00HK$0.00HK$0.00HK$0.00HK$0.09HK$0.00HK$0.00HK$0.10HK$0.00HK$0.00HK$0.00HK$0.00HK$0.18
2014HK$0.07HK$0.00HK$0.00HK$0.09HK$0.00HK$0.00HK$0.00HK$0.00HK$0.15

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%
0867.HK: 2.9%
China Medical System Holdings Ltd has a dividend yield of 2.93%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%
0867.HK: 34.1%
China Medical System Holdings Ltd has a payout ratio of 34.07%, which is quite average when compared to the overall market. This suggests that China Medical System Holdings Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-55.41%
-10.30%
0867.HK (China Medical System Holdings Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the China Medical System Holdings Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the China Medical System Holdings Ltd was 68.13%, occurring on Jul 30, 2024. The portfolio has not yet recovered.

The current China Medical System Holdings Ltd drawdown is 55.41%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-68.13%Jun 11, 2021770Jul 30, 2024
-67.76%Jan 11, 2018347Jun 17, 2019435Mar 18, 2021782
-44.71%Nov 17, 2014197Sep 2, 2015383Mar 27, 2017580
-32.58%Apr 8, 2011120Oct 4, 2011267Nov 1, 2012387
-26.75%Apr 25, 201397Sep 13, 201363Dec 16, 2013160

Volatility

Volatility Chart

The current China Medical System Holdings Ltd volatility is 22.76%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
22.76%
14.17%
0867.HK (China Medical System Holdings Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of China Medical System Holdings Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how China Medical System Holdings Ltd is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
0867.HK: 12.0
The chart displays the Price-to-Earnings (P/E) ratio for 0867.HK, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0867.HK has a P/E ratio of 12.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
2.04.06.08.010.0
0867.HK: 0.0
The chart shows the Price/Earnings to Growth (PEG) ratio for 0867.HK compared to other companies in the Drug Manufacturers - Specialty & Generic industry. 0867.HK currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
2.04.06.08.010.0
0867.HK: 2.8
This chart shows the Price-to-Sales (P/S) ratio for 0867.HK relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0867.HK has a P/S ratio of 2.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
2.04.06.08.010.0
0867.HK: 1.2
The chart illustrates the Price-to-Book (P/B) ratio for 0867.HK in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0867.HK has a P/B value of 1.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items